Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients
Reardon, David A., Conrad, Charles A., Cloughesy, Timothy, Prados, Michael D., Friedman, Henry S., Aldape, Kenneth D., Mischel, Paul, Xia, Jane, DiLea, Clifford, Huang, Jerry, Mietlowski, William, DugVolume:
69
Language:
english
Pages:
12
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-012-1854-6
Date:
June, 2012
File:
PDF, 416 KB
english, 2012